Importantly, we showed that local treatment with a non-toxic, non-persistent, physiological AhR ligand had beneficial effects on experimental leishmaniasis in susceptible mice, opening possibilities of further studies on the effects of AhR-signaling in infectious diseases like leishmaniasis. This evidence concerns the gene AHR and leishmaniasis.